Transition From COVID-19 Emergency: Demystify the FDA Requirements to Keep Your Device on The Market

How to get COVID-19 Devices to Market using FDA Emergency Use Authorization (EUA) programПодробнее

Out of EUA— FDA Guidance and RecommendationsПодробнее

FDA and Emergency ResponseПодробнее

COVID-19 and the FDA, with FDA Commissioner Stephan Hahn, MDПодробнее

4 - COVID-19: Updated FDA Emergency Use Authorization Webinar (3/31 edition)Подробнее

COVID-19: FDA Emergency Use Authorization Webinar (3/27 edition)Подробнее

Navigating Health Canada & FDA COVID-19 Medical Device AuthorizationПодробнее

What Emergency FDA Authorization Means for Covid-19 VaccineПодробнее

FDA Approves Remdesivir for COVID-19Подробнее

Emergency Use Authorization | Medical Devices Group COVID-19 Response TeamПодробнее

FDA Guidance on Manufacturing During COVID-19 and High AbsenteeismПодробнее

FDA Regulation of Diagnostic Testing and COVID-19Подробнее

OC LIFe (Lifesciences Innovators Forum) - COVID-19: Changes in FDA Approval and Clearance ProcessesПодробнее

The difference between FDA Approved and Emergency Use AuthorizationПодробнее

COVID-19: FDA Warning Letters Address Fraudulent Products and Failures to Meet EUA RequirementsПодробнее

How to Read an FDA Emergency Use AuthorizationПодробнее

News Wrap: FDA panel backs Moderna's COVID-19 vaccine for emergency useПодробнее

FDA Grants Emergency Use Authorization For COVID-19 Vaccine From Moderna | TODAYПодробнее

FDA to proceed with authorizing Pfizer’s COVID-19 vaccine for emergency useПодробнее